Hypertension Clinical Trial
Official title:
Where Should Automated Blood Pressures be Done? RCT of BpTRU Measurement in Private or Non-private Areas of Primary Care Offices
The use of automated blood pressure measurement (ABPM) devices in the office setting is
increasingly recognized as superior to manual BP measurement. Current guidelines recommend
that patients be alone in a quiet room, with no interactions with health care professionals
during the readings; in practice, this means using an exam room. However, we found no
evidence supporting the location of ABPM. Furthermore, exam rooms are constantly being used
in primary care offices, so this may not be practical in routine care.
For this study, fifty consecutive consenting patients age 18 or more in each of seven
community based primary care offices will randomly be allocated to either ABPM in an exam
room, or in a non-private area of the clinic. After being tested in the first location they
will then be tested in the second location with the same device. The main outcome will be
the mean value of the last five systolic blood pressures for each location within offices.
Secondary measures will include blood pressures for patients with or without hypertension, a
comparison of the initial and second set of blood pressures and of the effect of office
noise in decibels on BP readings.
New technology is more readily adopted if barriers to use are minimized. If we find no
differences in BP readings between office locations, clinicians will then have the option to
use an additional office area to implement the automated BP measurement device.
Following the design of our pilot study, patients consenting to two sets of blood pressure
readings will be randomly allocated using a random number table to either automated blood
pressure measurement using a BpTRU device in an exam room (private area without any traffic
or staff) with the door closed, or BpTRU in an open (non-private area) of the clinic with
routine office traffic and noise levels. Patients randomized to the private area first will
be subsequently tested in the non-private area and those randomized to the non-private area
first will then be tested in the private area. A single portable BpTRU machine will be used
for all recordings. A research assistant will be trained on the use of the equipment with at
least five supervised training readings. The BpTRU device will be placed on the patient's
arm and readings will be recorded by the research assistant. The first reading will be done
with the research assistant present to ensure proper placement and recording. The patient
will then be left alone for the subsequent five measurements separated by one minute
intervals. This will be immediately followed by a second set of readings in the alternate
location. During both sets of readings the patient will be seated comfortably in a chair
with arms and will be instructed not to talk or cross their legs. The same arm will be used
for both sets of measurements with the blood pressure cuff at heart level. The research
assistant will record the average of the last five out of six blood pressure readings for
each office location, in accordance with the manufacturer's recommendations and previous
studies.
The research assistant will record decibel levels in each location during BP readings using
a Reed Sound Level Meter C-322 (Reed Instruments, Ste-Anne-de-Bellevue, Quebec, Canada). The
sound level meter includes a data logger, and the mean decibel level per location for each
set of readings will be recorded. The assistant will be trained in the use of the sound
meter and logger and will use it during the five supervised BP training readings. The
research assistant will also measure and record the patient's weight in kg, height in cm,
and will collect information on patient's gender and self reported history of hypertension.
Planned sample size and analysis Our sample size is based on equivalence of BpTRU
measurement done in non private office areas as compared to measurement done in private
office areas, using the results of our pilot study. We consider differences of less than 5
mm Hg in systolic blood pressure to be clinically equivalent. In order to demonstrate
equivalence for our primary outcome, and accounting for clustering effect in primary care
offices, using a power of 80% and a two sided alpha level of 0.05 to conclude equivalency
for a difference of 5 mm Hg or less, we will need to recruit 350 patients. Our planned
recruitment is therefore fifty patients per office and seven office locations. 175 patients
(25 per office location) will be randomly allocated to BpTRU measurement in a private exam
room first and 175 will be allocated to an open area first.
Following the analytic methods used in our pilot study, we will use a random effect
regression model to account for repeated measures within each participant for analyzing the
data. Regression analysis will be undertaken to compare the measures and results will be
adjusted for clustering effect. All tests will be two-sided using an alpha level of 0.05.
;
Observational Model: Case-Crossover, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |